66 Vision Tech Co., Ltd. was established through the restructuring of the Suzhou Medical Instrument General Factory, which was founded in 1956. It is a national-level high-tech enterprise specializing in the R&D, manufacturing, and sales of ophthalmic medical devices, and serves as a vice-president unit of the Jiangsu Provincial Medical Device Industry Association. In 2020, 66 Vision became a wholly owned subsidiary of Jiangsu Yuwell Medical Equipment Co., Ltd. (hereinafter referred to as “Yuwell Medical”). The company’s main product lines include slit-lamp microscopes, surgical microscopes, microsurgical instruments, and electronic devices—four major categories.

The company has been recognized as one of China’s Top 50 Medical Industry Enterprises, an Advanced Collective within the national pharmaceutical sector, and an Advanced Collective at the provincial level in Jiangsu. It is a key high-tech enterprise under the National Torch Program and has successively received numerous honors, including Jiangsu Province’s “11th Five-Year Plan” Outstanding Enterprise Technology Center, Jiangsu Province’s Integrity Unit for Medical Device Manufacturers, Jiangsu Province’s Pilot Enterprise for the Integration of Informatization and Industrialization, Jiangsu Province’s Standardized Credit Management Enterprise, Suzhou’s Outstanding Private Enterprise, Suzhou’s Demonstration Enterprise for Specialization, Refinement, Distinctiveness, and Innovation, and the Award for Excellent Domestic Medical Equipment.

The company adheres to independent innovation and product development, maintaining a provincial-level enterprise technology center and the Jiangsu Provincial Engineering Research Center for Ophthalmic Diagnostic and Therapeutic Devices. It has also established a postdoctoral workstation within the company. The company actively pursues industry–university–research–medical collaboration as well as international technological partnerships, having forged long-term cooperative relationships with numerous universities and research institutes over the years. Through these efforts, it engages in international technical exchanges and joint R&D of new products and technologies, holding multiple invention patents. Furthermore, the company has repeatedly undertaken provincial‑level and higher projects, including National Torch Program initiatives, National Technological Innovation Projects, National 863 Program projects, Jiangsu Province’s Eleventh Five-Year Plan for High‑Tech Research, special funds for the commercialization of scientific and technological achievements, and international cooperation programs. The company has also spearheaded or participated in the formulation of several national standards and industry technical standards.

The company adheres to a development strategy of “professionalism, internationalization, high technology, high quality, brand building, customer first, and people‑oriented,” and is committed to strengthening quality management and enhancing product performance. Upholding this same strategy—“professionalism, internationalization, high technology, high quality, brand building, customer first, and people‑oriented”—the company earnestly pursues its vision of “going global and creating an internationally renowned brand,” while embracing the corporate spirit of “striving for world‑class excellence.” It will steadfastly uphold its mission of serving the ophthalmology field with sincere care for eye health.